Lucid Diagnostics Inc. (LUCD)

Lucid Diagnostics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	123	45	60	53	198	-
Market Cap Growth	-23.95%	-23.95%	12.22%	-73.09%	-	-
Enterprise Value	121	99	63	26	197	-
Last Close Price	1.42	0.82	1.41	1.36	5.37	-
PS Ratio	16.51	10.45	24.58	141.08	395.33	-
PB Ratio	22.88	8.42	-25.83	2.31	3.61	-
P/TBV Ratio	-	-	-	2.71	3.61	-
EV/Sales Ratio	27.89	22.71	25.79	68.61	394.82	-
Debt / Equity Ratio	3.94	3.94	-6.60	0.09	-	-
Asset Turnover	0.15	0.15	0.08	0.01	0.02	-
Inventory Turnover	22.94	22.94	30.74	11.97	0.88	-
Quick Ratio	1.01	1.01	0.71	2.83	12.90	0.02
Current Ratio	1.07	1.07	0.75	2.89	13.45	0.09
Return on Equity (ROE)	-2956.43%	-2956.43%	-507.97%	-144.42%	-136.23%	-
Return on Assets (ROA)	-99.28%	-99.28%	-101.38%	-76.84%	-56.01%	-320.54%
Return on Capital (ROIC)	-145.41%	-145.41%	-159.52%	-88.13%	-83.15%	-
Earnings Yield	-42.99%	-100.30%	-88.24%	-105.61%	-14.21%	-
FCF Yield	-36.03%	-97.89%	-55.35%	-57.52%	-9.38%	-
Buyback Yield / Dilution	-20.98%	-20.98%	-15.44%	-94.44%	-31.81%	-0.03%

Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q